DigestRedComo funciona
Red
/
Empresas
Ne
No verificado

Neurotech Pharmaceuticals, Inc.

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaÓpticaSalud

6 Comunicados de prensa

Ver todos los comunicados de prensa
29/09/2025
Biotecnología
Salud
Farmacéutica
Óptica
Industria
Neurotech Granted Permanent J-Code (J3403) for ENCELTO™ (revakinagene taroretcel-lwey), Effective October 1, 2025
Fuente
Neurotech Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
02/09/2025
Neurotech Appoints Peter J. McDonnell, M.D., to the Company’s Board of Directors
Fuente
Neurotech Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
11/08/2025
Salud
Higiene alimentaria
Material médico sanitario
Farmacéutica
Óptica
Biotecnología
Industria
First FDA-Approved Treatment for MacTel Performed
Fuente
Neurotech Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
21/04/2025
Neurotech Appoints Beth Marsh as Chief Commercial Officer
Fuente
Neurotech Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
06/03/2025
Industria
Higiene alimentaria
Salud
Farmacéutica
Óptica
Biotecnología
Neurotech’s ENCELTO™ (revakinagene taroretcel-lwey) Approved by the FDA for the Treatment of Macular Telangiectasia Type 2 (MacTel)
Fuente
Neurotech Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
08/11/2024
Industria
Salud
Higiene alimentaria
Medicina - Varios
Farmacéutica
Óptica
Biotecnología
Neurotech Provides Update on BLA for NT-501 as a Treatment for Macular Telangiectasia Type 2 (MacTel)
Fuente
Neurotech Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0